A group of about 150 major international investors, including the Dutch insurance groups Achmea and Aegon, are calling on the pharmaceutical industry and world leaders to distribute corona vaccines effectively, fairly and equitably.
In many poor countries, vaccinations against the corona virus have not yet started.
The parties collectively have assets under management of more than $ 14,000 billion. Of the 128 million doses administered so far, more than three-quarters have been given in ten rich countries, accounting for 60 percent of the world economy. No vaccine has yet been administered in 130 countries, with a total of 2.5 billion people, the investors say.
More than 9 trillion loss
“Many poor countries currently have insufficient access to the developed vaccines. This has a major impact on billions of people around the world and also increases the risk of mutations. Better access to vaccines for these countries is therefore important to get Covid-19 under global control. This is also important from an economic point of view. Article link https://www.news1.news/news/2021/02/major-investors-want-a-fair-distribution-of-corona-vaccines-between-rich-and-poor-countries.html
The global economy could lose $ 9.2 trillion if poor countries’ access to vaccines is not improved, “Achmea writes.
‘Give licenses to developing countries’
The leaders of the twenty richest industrial countries are now called upon to support the so-called ACT-Accelerator. Article link https://www.news1.news/news/2021/02/major-investors-want-a-fair-distribution-of-corona-vaccines-between-rich-and-poor-countries.html
The ACT-Accelerator is a partnership of the World Health Organization (WHO), the Bill & Melinda Gates Foundation and the World Bank, among others, with the aim of organizing worldwide access to vaccines.
Pharmaceutical companies are also asked to grant licenses to developing countries and to support them in the production of vaccines. In addition, the signatories are open to new forms of financing for combating corona, for example through so-called ‘vaccine bonds’. That money could then finance vaccination campaigns in poor countries, for example.
You can follow these topics
I hope you are in health and well.
I offer you important instructions regarding this article
- The article has been translated based on the content of the Source link below these instructions
If there is any problem related to the content, copyright, correctness of the information contained in this article, or If there are errors in the language, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
- We only want readers to access information quickly and easily using other multilingual content, rather than information only available in a specific language.
- We always respect the copyright of the author's content and always include
the original link of the Source Article , and if the author does not agree, leave the report below the article, the article will be edited or deleted at the author's request. Thank you so much! Warm greetings!